期刊文献+

Artificial intelligence in liver ultrasound 被引量:4

下载PDF
导出
摘要 Artificial intelligence(AI)is playing an increasingly important role in medicine,especially in the field of medical imaging.It can be used to diagnose diseases and predict certain statuses and possible events that may happen.Recently,more and more studies have confirmed the value of AI based on ultrasound in the evaluation of diffuse liver diseases and focal liver lesions.It can assess the severity of liver fibrosis and nonalcoholic fatty liver,differentially diagnose benign and malignant liver lesions,distinguish primary from secondary liver cancers,predict the curative effect of liver cancer treatment and recurrence after treatment,and predict microvascular invasion in hepatocellular carcinoma.The findings from these studies have great clinical application potential in the near future.The purpose of this review is to comprehensively introduce the current status and future perspectives of AI in liver ultrasound.
出处 《World Journal of Gastroenterology》 SCIE CAS 2022年第27期3398-3409,共12页 世界胃肠病学杂志(英文版)
基金 Supported by National Natural Science Foundation of China,No.82071953 2020 Hunan Province Clinical Medical Technology Innovation Guidance Project.
  • 相关文献

参考文献1

二级参考文献27

  • 1Altekruse SF, McGlynn KA, Reichman ME. Hepatocellu- lar carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27: 1485-1491.
  • 2El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118-1127.
  • 3Bruix J, Sherman M. Management of hepatocellular carci- noma: an update. Hepatology 2011; 53:1020-1022.
  • 4European Association For The Study Of The Liver; Euro- pean Organisation For Research And Treatment Of Can- cer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepato12012; 56:908-943.
  • 5Dietrich CF. Characterisation of focal liver lesions with con- trast enhanced ultrasonography. Eur J Radiol 2004; 51 Suppl: S9-17.
  • 6Rettenbacher T. Focal liver lesions: role of contrast-en- hanced ultrasound. Eur J Radio12007; 64:173-182.
  • 7Albrecht T, Blomley M, Bolondi L, Claudon M, Correas JM, Cosgrove D, Greiner L, Jager K, Jong ND, Leen E, Lencioni R, Lindsell D, Martegani A, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004; 25:249-256.
  • 8Lencioni R, Piscaglia F, Bolondi L. Contrast-enhanced ultra- sound in the diagnosis of hepatocellular carcinoma. J Hepa- tol 2008; 48:848-857.
  • 9Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 2009; 50:791-798.
  • 10Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005; 42- 27-34.

共引文献12

同被引文献22

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部